10A-AZALIDE COMPOUND CROSSLINKED AT 10A- AND 12-POSITIONS
申请人:Sugimoto Tomohiro
公开号:US20110237784A1
公开(公告)日:2011-09-29
A novel 10a-azalide compound crosslinked at the 10a- and 12-positions, which is represented by the following formula, and is effective on even
Hemophilus influenzae
, or erythromycin resistant bacteria (e.g., resistant pneumococci and streptococci).
The present invention relates to acetyl coenzyme-A carboxylase (“ACC”) inhibiting compounds of the formula
wherein the variables are as defined herein. In particular, the present invention relates to ACC1 and/or ACC2 inhibitors, compositions of matter, kits and articles of manufacture comprising these compounds, methods for inhibiting ACC1 and/or ACC2, and methods of making the inhibitors.
ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE THEREOF
申请人:CALITHERA BIOSCIENCES, INC.
公开号:US20220363709A1
公开(公告)日:2022-11-17
The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cancer using the novel heterocyclic compounds of the invention.